1. Home
  2. ARDX vs TWO Comparison

ARDX vs TWO Comparison

Compare ARDX & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARDX
  • TWO
  • Stock Information
  • Founded
  • ARDX 2007
  • TWO 2009
  • Country
  • ARDX United States
  • TWO United States
  • Employees
  • ARDX N/A
  • TWO N/A
  • Industry
  • ARDX Biotechnology: Pharmaceutical Preparations
  • TWO Real Estate Investment Trusts
  • Sector
  • ARDX Health Care
  • TWO Real Estate
  • Exchange
  • ARDX Nasdaq
  • TWO Nasdaq
  • Market Cap
  • ARDX 882.9M
  • TWO 1.1B
  • IPO Year
  • ARDX 2014
  • TWO 2009
  • Fundamental
  • Price
  • ARDX $6.55
  • TWO $10.07
  • Analyst Decision
  • ARDX Strong Buy
  • TWO Buy
  • Analyst Count
  • ARDX 9
  • TWO 8
  • Target Price
  • ARDX $10.50
  • TWO $12.50
  • AVG Volume (30 Days)
  • ARDX 3.2M
  • TWO 1.8M
  • Earning Date
  • ARDX 10-30-2025
  • TWO 10-27-2025
  • Dividend Yield
  • ARDX N/A
  • TWO 15.45%
  • EPS Growth
  • ARDX N/A
  • TWO N/A
  • EPS
  • ARDX N/A
  • TWO N/A
  • Revenue
  • ARDX $386,146,000.00
  • TWO $257,735,000.00
  • Revenue This Year
  • ARDX $17.79
  • TWO N/A
  • Revenue Next Year
  • ARDX $27.82
  • TWO N/A
  • P/E Ratio
  • ARDX N/A
  • TWO N/A
  • Revenue Growth
  • ARDX 83.88
  • TWO N/A
  • 52 Week Low
  • ARDX $3.21
  • TWO $9.50
  • 52 Week High
  • ARDX $7.18
  • TWO $14.28
  • Technical
  • Relative Strength Index (RSI)
  • ARDX 71.64
  • TWO 51.69
  • Support Level
  • ARDX $6.47
  • TWO N/A
  • Resistance Level
  • ARDX $6.78
  • TWO $10.58
  • Average True Range (ATR)
  • ARDX 0.19
  • TWO 0.17
  • MACD
  • ARDX -0.05
  • TWO -0.36
  • Stochastic Oscillator
  • ARDX 67.18
  • TWO 95.13

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

About TWO Two Harbors Investment Corp

Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.

Share on Social Networks: